Kotak Pre-IPO fund to buy into diagnostic chain Neuberg

Kotak Pre IPO Opportunities Fund is in advanced talks to acquire a 15% stake in Neuberg Diagnostics for approximately Rs 450 crore. Neuberg's chairman, GSK Velu, plans to use the funds for acquisitions and expansion before a potential IPO next year. The diagnostics chain operates in multiple countries and processes millions of patient samples annually.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Y9M2Hcw
via IFTTT

Read More

Carlyle Group sells 4.3% in Indegene for ₹636 cr

Global investment firm Carlyle Group divested a 4.3% stake in Indegene for ₹636 crore via open market transactions, reducing its holding to 10.22%. Capital Group also sold a 2.24% stake in Medi Assist Healthcare Services for nearly ₹93 crore, trimming its holding to 0.7%.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/GlQHskh
via IFTTT

Read More

Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms

Novo Nordisk's team in India is urging the company to launch its popular weight-loss drug, Wegovy, next year to stay ahead of rival Eli Lilly. Concerns have been raised about Novo potentially lagging behind if Wegovy is not introduced before Lilly's drug, Mounjaro, in the Indian market where demand is high.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ikUSv43
via IFTTT

Read More

Parents challenge Covid vaccine safety in Supreme Court, cite adverse effects

Parents of children who died following Covid-19 vaccinations have filed a new affidavit in the Supreme Court, citing recent studies that highlight the "poor safety" of the vaccines and an increase in mortality rates post-vaccination. The affidavit includes testimonies from 40 individuals who either died or suffered severe adverse effects after receiving the vaccine.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Rj9OLmz
via IFTTT

Read More

Flipkart Minutes eyes 10-min drug delivery to outpace its rivals

Flipkart is preparing to launch a rapid delivery service named Flipkart Minutes, targeting medicine deliveries within 10 minutes. The service will use local chemists in metro areas for inventory, complying with India's drug regulations. This quick commerce initiative aims to tap into the largely unexplored market of medical deliveries, promising better margins than food and groceries.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Z3lxawe
via IFTTT

Read More

Milestone for India: Indigenous E-beam technology sterilises 50 lakh medical devices

Indore's electron beam radiation technology sterilized 50 lakh medical devices. This milestone was achieved by a premier institute of the Department of Atomic Energy. The facility started in October 2022 and has made India a part of the select group of countries using advanced radiation technology. The technology has diverse applications including medical device sterilization and more.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/SRn5c61
via IFTTT

Read More

Reliance Industries-powered Strand Life Sciences unveils CancerSpot test for early detection of multiple cancers

Strand Life Sciences, a subsidiary of Reliance Industries, has introduced CancerSpot, a blood-based test for early cancer detection. It employs methylation profiling technology to identify tumor DNA fragments from blood samples. The test is tailored using data from Indian cohorts, making it relevant globally. This initiative aligns with Reliance's goal of advancing healthcare through genomics.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/AKzWTGJ
via IFTTT

Read More

Internet searches on mental health increased 41% this year: Report

Internet searches related to mental health in India surged by 41% in the first 10 months of this year compared to 2023, showing increasing recognition of mental wellbeing. Healthcare searches overall rose by 23%, with notable growth in non-metropolitan cities. Significant increases were seen in searches for psychologists, orthopaedic care, gynaecologists, and Ayurvedic doctors.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/sW894F3
via IFTTT

Read More

Biocon Biologics gets US nod to launch Stelara biosimilar

Biocon Biologics has secured USFDA approval to launch the biosimilar of Janssen's Stelara by February 2025, targeting autoimmune conditions like Crohn's disease and plaque psoriasis. Despite competition from five other biosimilars, this launch is anticipated to significantly boost Biocon’s revenue and profitability.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/l0cAdEu
via IFTTT

Read More

Want a slimmer face? Try these 7 easy exercises

Want to slim down your face naturally? These 7 simple face exercises can help tone muscles, reduce fat, and give you a more defined look—no equipment needed!

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/vJM3uDq
via IFTTT

Read More